Treatment.com International Inc (939.MU)
Chart Events
Performance Outlook
| Previous Close | 0.0202 |
| Open | 0.0202 |
| Bid | 0.0200 x N/A |
| Ask | 0.0404 x N/A |
| Day's Range | 0.0202 - 0.0202 |
| 52 Week Range | 0.0200 - 0.3260 |
| Volume | |
| Avg. Volume | 775 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for 939.MU
Related Research
- GlobeNewswire
Treatment’s Debut AI-driven Health App Getting Five Star Reviews from Doctors
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), is a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions. Treatment’s landmark debut product, the Treatment Digital Health App, has been garnering five-star reviews on both the Apple App Store and the Google Play Store. Users’ comments
- GlobeNewswire
Treatment Announces Convertible Debenture Private Placement
VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions, announces the proceeding of a non-brokered private placement, raising aggregate gross proceeds of up to $1,250,000 in unsecured convertible debentures (the “Private Placement”). Each
